Racial variations in the performance of prostate specific antigen and prostate specific antigen density in the era of extended prostate biopsy schemes
- PMID: 18707710
- DOI: 10.1016/j.juro.2008.06.031
Racial variations in the performance of prostate specific antigen and prostate specific antigen density in the era of extended prostate biopsy schemes
Abstract
Purpose: The incidence of prostate cancer is known to vary as a function of race. To date few studies have evaluated the performance of the prostate specific antigen test and its indexes in unique racial populations. We examined the performance of prostate specific antigen, prostate specific antigen density and transition zone density in racial groups undergoing an extended prostate biopsy scheme.
Materials and methods: A retrospective review was performed of prospectively collected data on 1,115 white, 288 black and 161 Asian/Pacific Islander men referred for prostate needle biopsy. All participants had not undergone previous biopsy. ROC curves stratified by race were ascertained for prostate specific antigen, prostate specific antigen density and transition zone density for detecting cancer and high grade cancer (Gleason 3 + 4 or greater).
Results: Across all races prostate specific antigen density outperformed prostate specific antigen for detecting any prostate cancer and high grade cancer. Prostate specific antigen and prostate specific antigen density performed best for diagnosing high grade cancer and diagnosing cancer in men with an abnormal digital rectal examination. When comparing differing races, prostate specific antigen density performed the best in Asian/Pacific Islander men for high grade cancer detection. The performance of transition zone density was inferior to that of prostate specific antigen density.
Conclusions: Racial variations exist in the performance of prostate specific antigen and prostate specific antigen density. In men of Asian/Pacific Islander descent prostate specific antigen and prostate specific antigen density perform better than in white men, especially for diagnosing clinically significant, high grade prostate cancer. In general prostate specific antigen and prostate specific antigen density perform equally well in white and black populations.
Similar articles
-
The performance of prostate specific antigen, prostate specific antigen density and transition zone density in the era of extended biopsy schemes.J Urol. 2008 May;179(5):1756-61; discussion 1761. doi: 10.1016/j.juro.2008.01.033. Epub 2008 Mar 17. J Urol. 2008. PMID: 18343425
-
Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.J Natl Cancer Inst. 1997 Jan 15;89(2):134-8. doi: 10.1093/jnci/89.2.134. J Natl Cancer Inst. 1997. PMID: 8998182
-
Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trial.Urology. 2000 Mar;55(3):372-6. doi: 10.1016/s0090-4295(99)00547-6. Urology. 2000. PMID: 10699613 Clinical Trial.
-
Prospective evaluation of prostate specific antigen density and systematic biopsy for detecting prostate cancer in Japanese patients with normal rectal examinations and intermediate prostate specific antigen levels.J Urol. 1997 Sep;158(3 Pt 1):861-4. doi: 10.1097/00005392-199709000-00046. J Urol. 1997. PMID: 9258099 Review.
-
Temporal trends and racial disparities in global prostate cancer prevalence.Can J Urol. 2014 Oct;21(5):7496-506. Can J Urol. 2014. PMID: 25347377 Free PMC article. Review.
Cited by
-
External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort.Asian J Androl. 2012 Sep;14(5):738-44. doi: 10.1038/aja.2012.28. Epub 2012 May 7. Asian J Androl. 2012. PMID: 22561907 Free PMC article. Clinical Trial.
-
Evaluation of the Prostate Cancer Prevention Trial Risk calculator in a high-risk screening population.BJU Int. 2010 Feb;105(3):334-7. doi: 10.1111/j.1464-410X.2009.08793.x. Epub 2009 Aug 25. BJU Int. 2010. PMID: 19709072 Free PMC article.
-
Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis.Ann Fam Med. 2018 Mar;16(2):149-154. doi: 10.1370/afm.2205. Ann Fam Med. 2018. PMID: 29531107 Free PMC article.
-
Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer.Prostate Int. 2013;1(1):23-30. doi: 10.12954/PI.12003. Epub 2013 Jan 31. Prostate Int. 2013. PMID: 24223398 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical